Indeed, adequate intratumoral IL-15 levels within the TME are essential for optimal antitumor efficacy, with diminished local IL-15 production closely linked to increased tumor relapse rates and decreased patient survival outcomes [33]. Here, IL15 is linked to neoplasm.